DIM
GOSS icon

DC Investments Management’s Gossamer Bio GOSS Stock Holding History

DC Investments Management’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-33,445
Closed -$725K – 348
2019
Q1 		$725K Buy
+33,445
New +$697K 0.46% 37

Other funds holding GOSS

OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
HIM
Hillhouse Investment Management Grand Cayman, Cayman Islands $3.13B AUM 7.29% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

DC Investments Management's GOSS Position: Q2 2019 in Review

DC Investments Management sold out of Gossamer Bio (GOSS) in Q2 2019, closing a stake of 33,445 shares — an estimated $725K sold.

DC Investments Management first reported a position in GOSS in Q1 2019 and held it in 1 quarter. The position peaked at $725K in Q1 2019. 74 funds tracked by Wall St. Rank hold GOSS as of Q2 2019.

  • DC Investments Management reported no remaining Gossamer Bio position as of Q2 2019 after selling out during the quarter.
  • DC Investments Management sold 33,445 Gossamer Bio shares in Q2 2019, an estimated $725K.
  • DC Investments Management first reported a position in Gossamer Bio in Q1 2019 and held it in 1 quarter.
  • DC Investments Management's Gossamer Bio position peaked at $725K in Q1 2019.
  • 74 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2019.

Based on DC Investments Management's 13F filing for Q2 2019, filed 12 Aug 2019.